Florida Administrative Code
Fla. Admin. Code R. 2-40.007 (2026)
Rescheduling of a Drug Product in Finished Dosage Formulation That Has Been Approved by the U.S. Food and Drug Administration That Contains Cannabidiol (2-[1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol) Derived from Cannabis and No More Than 0.1 Percent (w/w) Residual Tetrahydrocannabinols
✓ current as of September 2026
Find cases:
SyfertCases citing this section
FLRulesflrules.org (official)
ChapterChapter 2-40
CornellLII Search
CasesGoogle Scholar
Under the authority of Section 893.0355, F.S., a drug product in finished dosage formulation that has been approved by the U.S. Food and Drug Administration that contains cannabidiol (2-[1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol) derived from cannabis and no more than 0.1 percent (w/w) residual Tetrahydrocannabinols, is hereby rescheduled from a Schedule I to a Schedule V controlled substance.
Rulemaking Authority 893.0355 FS. Law Implemented 893.0355 FS. History–New 2-7-19.
Effective: 2/7/2019.